![]() ![]() Providers should contact distributors and local vendors about remaining supply. Some formulations of vaccine should still be available for purchase. Influenza vaccine pre-booking typically occurs between January and March. Can I still buy influenza vaccine for the 2022-2023 season? The remaining vaccine will be produced using cell-based or recombinant technology. ![]() flu vaccine supply for 2022-2023 will be produced using egg-based manufacturing?Īpproximately 80% of the projected vaccine supply produced for the 2022-2023 flu season will be produced using egg-based manufacturing technology. There will not be any trivalent flu vaccine available. How much quadrivalent (four-component) vaccine is expected to be available for the 2022-2023 season?įor the 2022-2023 season, 100% of the projected vaccine supply produced will be quadrivalent (4-component) vaccines. For the 2022-2023 season, only multidose vial formulations of influenza vaccines will contain thimerosal.Īpproximately 93% of projected vaccine supply produced for the 2022-2023 flu season will be thimerosal-free or thimerosal-reduced (i.e., preservative-free). How much thimerosal-free influenza vaccine is expected to be available for the 2022-2023 season?įor the 2022-2023 season, manufacturers will produce influenza vaccines that do not contain thimerosal and some vaccines that do contain thimerosal. There also may be other locations in your area that have vaccine available.ĬDC will continue to provide weekly updates on total flu vaccine doses distributed throughout the 2022-2023 flu season. To make sure your provider has flu vaccine available, call ahead to confirm availability. Additionally, because vaccine manufacturing has been extended to support the production of a record number of flu vaccine doses this year, providers are likely to receive more shipments throughout the season. However, as supplies become available in increasing numbers, supply is expected to catch up with demand. An allocation system can initially limit the size of individual orders. While no important delays have been reported, in some places, robust demand for vaccine and supplies required to support flu vaccination efforts, like needles or syringes, may mean that some providers run out of vaccine or other supplies before their next shipment has arrived. Ideally, the intervals between shipments are short so that each provider has a continuous supply and can continue vaccinating patients without interruption. CDC encourages manufacturers and distributors to use a distribution strategy in which providers receive smaller shipments to allow as many providers as possible to begin vaccination activities early in the vaccination season. Influenza vaccine production and distribution in the U.S. Are there delays in the distribution of influenza vaccine?Ĭurrently, influenza vaccine manufacturers are not reporting any expected delays in national flu vaccine supply or distribution this season. Will there be enough supply of high-dose, recombinant and adjuvanted flu vaccines available for people 65 years and older this season to meet the demand created by the new preferential recommendation?ĬDC is not aware of any supply problems with these higher-dose or adjuvanted flu vaccines as a group however, flu vaccine manufacturers are the best source for information on supplies of their flu vaccines. Most will be thimerosal-free or thimerosal-reduced vaccine (93%), and about 20% of flu vaccines will be egg-free. All flu vaccines for the 2022-2023 season will be quadrivalent (four component). These projections may change as the season progresses. Vaccine manufacturers have projected that they will supply the United States with as many as 173.5 million to 183.5 million doses of influenza vaccines for the 2022-2023 season. Flu vaccine is produced by private manufacturers, so supply depends on manufacturers.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |